, ZnODPc, incorporated into a Cremophor emulsion, was assayed for its pharmacokinetic and phototherapeutic properties in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The phthalocyanine was injected intravenously (i.v.) in three doses, i.e. 1.46, 0.73 and 0.37 ttmol kg-' body weight. In all cases, the octadecyl-substituted phthalocyanine showed an unusually high affinity for serum low-density lipoproteins (LDLs) and a high efficiency and selectivity of tumour targeting: the maximum accumulation in the tumour occurred at 24 h after injection, whereas no detectable amount of phthalocyanine was recovered from the muscle, i.e. the peritumoral tissue, between I h and 1 week after injection. At the same time, low amounts of phthalocyanine were recovered from skin and then only at short times after injection, with skin photosensitivity rapidly disappearing and the phthalocyanine present in the serum only. Tumour photosensitisation studies were carried out at 24 h after administration of 1.46 ,umol kg-' ZnODPc and showed that this phthalocyanine has a very high phototherapeutic efficiency; this is probably a consequence of the multiple mechanisms by which the phthalocyanine induces tumour damage, involving both direct modification of malignant cells and impairment of blood flow, as well as the alteration of a variety of subcellular components, such as mitochondria, the rough endoplasmic reticulum, the perinuclear membrane and, occasionally, cell nuclei. Tumour necrosis appears to be the consequence of both random cell death and apoptosis.
The chemical structure of porphyrinoid derivatives appreciably affects their pharmacokinetic behaviour in tumourbearing animals, including their distribution among the various compartments of cells or tissues (Jori, 1989; Henderson and Dougherty, 1992) ; this in turn influences the efficiency and mechanism by which photoactivated porphyrinoids induce tumour necrosis in photodynamic therapy (PDT) (Hamblin and Newman, 1994) . Several factors have been identified as modulators of the phototherapeutic activity: thus, hydrophobic dyes exhibit a particularly high affinity for malignant cells, while more hydrophilic compounds are preferentially released to the extracellular matrix, hence they mainly photosensitise through damage to the vascular system (Henderson and Bellnier, 1989; Moan and Berg, 1992) ; in several cases, the selectivity of tumour targeting can be enhanced by the association of the photosensitiser with suitable delivery systems before systemic injection (Jori, 1992; Garbo, 1990) ; the presence of electrically charged or bulky peripheral substituents and/or axial ligands to the centrally coordinated metal ions minimises the tendency of porphyrinoids to undergo aggregation which often lowers their photosensitising efficiency (Jori, 1995) ; lastly, cationic dyes appear to develop a very specific interaction with the mitochondria of neoplastic cells (Dougherty, 1993) .
On these bases, it appears important to obtain detailed information on structure-activity relationships, especially for those second-generation PDT agents that are being tested at the clinical level or are approaching clinical trials. For some years, we have focused our investigations on phthalocyanines, whose spectral properties and -in vivo biodistribution are markedly influenced by the nature of the coordinated metal ion, its axial ligands and the peripheral side groups from the isoindole moieties (Jori and Reddi, 1991; Spikes, 1986; Soncin et al., 1995a) . In this paper, we report our findings on a novel highly substituted phthalocyanine, namely 1,4,8,11,15,18,22, 25-octadecylphthalocyaninato Zinc(II) (ZnODPc), which was shown to possess excellent photophysical properties in vitro (Cook et al., 1995) ; moreover, preliminary in vivo investigations appear to suggest that ZnODPc displays unusual pharmacokinetic and phototherapeutic features (Cook et al., 1994 ) that should be explored further. Our studies were performed with Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma, i.e. an animal model which has been frequently used in our laboratories (Reddi et al., 1987; Cuomo et al., 1991; Villanueva et al., 1994) for experimental PDT studies, so that meaningful comparisons between ZnODPc and other PDT agents could be made.
Materials and methods

Animals and tumour
Female Balb/c mice, 20-22 g body weight, were purchased from Charles River (Como, Italy) and housed in standard cages with free access to tap water and normal dietary food. The mice were treated according to the guidelines established by the Italian committee for humane care of experimental animals. Tumour implantation was performed by intramuscular injection of a sterile aqueous suspension (0.2 ml) of 106 cells of MS-2 fibrosarcoma into the right hind leg; the tumour was originally obtained from the Istituto Nazionale dei Tumori (Milan, Italy) . No spontaneous regression or remission of the tumour was observed during our investigations.
Chemicals
The synthesis of 1,4,8,11,15,1 8,22 ,25-octakis-decylphthalocyaninatozinc (ZnODPc, molecular weight 1700) has been described elsewhere (Cook et al., 1995) . The phthalocyanine was incorporated into aqueous emulsions of Cremophor EL (Sigma) (Cook et al., 1994) , and its concentration was determined by diluting a known aliquot of the emulsion into a known excess of tetrahydrofuran and measuring the absorbance at 701 nm (c=2.01 x 105 dm3 mol 'cm -). In general, the ZnODPc concentration in the emulsion was c. , 1987) . Under these experimental conditions, more than 95% phthalocyanine was recovered from the tissue specimens.
In parallel experiments, 2 ml of pooled mouse sera obtained at 24 h after i.v. injection of ZnODPc were subjected to discontinuous density gradient ultracentrifugation (Havel et al., 1985) , in order to isolate the following serum protein fractions: very low-density (VLDL), lowdensity (LDL), high-density (HDL) lipoproteins, and heavy proteins (d> 1.2, mainly globulins and albumin). Then, 0.4 ml of the individual fractions were added with 0.4 ml of 4% aqueous SDS, diluted with 1.5 ml of tetrahydrofuran and the amount of associated ZnODPc was determined by spectrofluorimetric analysis.
Phototherapeutic studies Irradiation of the tumour-bearing mice was performed at 24 h after i.v. injection of 1.46 imol kg-' Cremophorincorporated ZnODPc by 620-700 nm light isolated from the emission of a quartz/halogen lamp (Teclas, Lugano, Switzerland) by means of a band-pass filter. The light source was operated at 230 mW cm-2 for a total delivered light dose of 400 J cm-2. The beam was piloted to the irradiation site by a bundle of optical fibres whose tip (diameter 0.8 cm) was kept at a distance of 1 cm from the mouse skin. Previous studies (Soncin et al., 1995b) have shown that under these irradiation conditions the tumour temperature does not rise beyond 38°C, so that any hyperthermal effect could be discounted (Biolo et al., 1994) . During irradiation the mice were anaesthetised by intraperitoneal administration of ketalar (0.5 ml per 20 g of body weight).
The growth of the fibrosarcoma in the phototreated animals was compared with that observed for control unirradiated mice.
At predetermined post-irradiation times, the mice were sacrificed by prolonged exposure to ether vapours, the tumour was rapidly excised and fixed with glutaraldehyde for ultrastructural studies (Milanesi et al., 1990) . The ultrathin sections were analysed by an Hitachi H-600 electron microscope. At least three mice for each postirradiation time were examined.
Skin photosensitivity studies
Healthy Balb/c mice that received 1.46 Mmol kg-' ZnODPc were irradiated in the right hind leg at 3 h, 15 h and 24 h after i.v. administration of the phthalocyanine. The light source was operated at a fluence rate of 230 mW cm-2, in the absence of band-pass filters, so that the incident light extended from 360-800 nm; the total light dose was 400 J cm-2. The skin reponse to the phototreatment was assessed at daily intervals for about 1 week after irradiation.
In a different set of experiments, control and phototreated mice (irradiation at 3 h after injection) were sacrificed at 3 h after the end of irradiation. The irradiated skin area and an equivalent sample of unirradiated skin were taken and fixed for optical microscopy (Milanesi et al., 1991) . Observations were carried out with a Leitz Dialux 22 instrument.
Results
Pharmacokinetic studies
The distribution of ZnODPc among plasma proteins of Balb/ c mice was studied at 24 h after i.v. injection of different phthalocyanine doses (Table I ). This time interval was selected since the release of hydrophobic substrates from Cremophor to serum proteins has been shown to be a slow process (Kongshaug et al., 1992) , hence at shorter post- Table III and represent the averaged recoveries from five independently analysed mice at each time point. It is apparent that the maximum accumulation of ZnODPc in tissues increases with the injected dose. In particular, for liver, spleen and tumour, the kinetics of phthalocyanine uptake is particularly slow and the intratissular concentration reaches maximum values at 24 h after injection. In no case is any detectable amount of phthalocyanine found in extracts from the muscle and skin.
Since the rate of photosensitiser clearance from the organism is an important factor for the design of new phototherapeutic agents, we also examined the retention of ZnODPc in selected tissues of healthy Balb/c mice up to 10 weeks after i.v. administration of 1.46 imol kg-' phthalocyanine. The recoveries are shown in Table IV ; such recoveries are often higher (e.g. see skin and spleen) than those found for the same tissues in tumour-bearing mice. This (Reddi et al., 1987) and reflects the larger serum concentration of phthalocyanine in the absence of the fibrosarcoma.
Phototherapeutic studies
On the basis of the pharmacokinetic data, PDT studies with Balb/c mice bearing an intramuscular MS-2 fibrosarcoma were performed at 24 h after i.v. injection of 1.46 ymol kg-' ZnODPc. As previously observed (Cook et al., 1994) , the phototreated animals exhibit a significantly slower growth of the tumour compared with unirradiated or irradiated but unsensitised animals. The overall effect was similar to that obtained by previous authors (Biolo et al., 1996; Valles et al., 1995) for other moderately vascularised tumours at equivalent light doses. Electron microscopy analysis of tumour specimens taken from ZnODPc-injected and unirradiated mice show that the phthalocyanine per se causes no detectable alterations of the ultrastructural properties of the fibrosarcoma.
However, in ZnODPc-photosensitised tumours, at 1 h after the end of PDT both neoplastic cells and blood capillaries appear to be well preserved with the exception of some swelling of mitochondria, which is especially evident in tumour cells (Figure 1 ). The photodamage becomes more Figure 1 Tumour specimen obtained at 1 h after PDT (x 5500). The sample differs from those obtained from control tumours by a marked swelling of some mitochondria (m). (Figure 3) . In any case, the photoinduced structural modifications are especially extensive at the level of the cell membranes, whereas vacuoles occupy a large fraction of the cytoplasmic space and the perinuclear membrane is partially detached and discontinuous. The nuclei appear to be markedly damaged only in massively necrotic areas of the tumour tissue, which also show the presence of granular material probably originating from the destruction of neoplastic cells (Figure 4) . Interestingly, in micrographs obtained from tumour specimens taken at short post-irradiation time intervals (1-6 h), one can observe some unusual ultrastructural features, including a marked vesiculation of cellular nuclei (Figures 5  and 6 ). No similar alterations have been found previously in our electron microscopy analyses of different tumour models (including the MS-2 fibrosarcoma) after PDT treatment with a variety of phthalocyanines or other tetrapyrrolic derivatives. The formation of the vesicles must be the consequence of photochemically induced damage, since we could not detect any analogous alteration in mice that were injected with ZnODPc but were not exposed to light.
Lastly, as shown in Figures 7 and 8 , some tumour cells that are present in partially damaged areas exhibit ultrastructural aspects typical of apoptotic processes: thus, chromatin is condensed and localised at one nuclear pole, while several blebs are formed in the swollen perinuclear membrane; the latter also shows a few evident gaps through which some nuclear material could move into the cytoplasm leading to the formation of compact chromatin masses (Figure 8 ). It is unlikely that the observed ultrastructural changes reflect the occurrence of spontaneous apoptosis, since no similar ultrastructural details could be identified in all the twelve thin sections that were analysed from control mice.
Skin photosensitisation studies Mice irradiated at 3 h after ZnODPc injection exhibit an important cutaneous response: a marked skin swelling occurs within 12 h from the end of the phototreatment and is followed by the appearance of oedema and erythema after c. 48 h. The lesions undergo a progressive regression, although re-epithelisation is still incomplete after I week. However, no skin alteration can be detected in mice exposed to white light at 15 h and 24 h after i.v. administration of ZnODPc. These qualitative observations are fully supported by histological examination of skin specimens taken from control and phototreated mice. Typical pictures of unirradiated skin obtained using the optical microscope are shown in Figures 9 and 10 and display the characteristic structure of mouse skin. A closely similar organisation of the epidermal and dermal layers is exhibited in areas of skin from photosensitised mice that are distal to the irradiated site (mice injected with ZnODPc 3 h before PDT treatment) (Figure 11 ). However, as the analysed samples are chosen from areas closer to the irradiated site, the indications for photoinduced damage become more and more evident. In particular, one can detect a loss of organisation in the deeper districts of the dermis especially at the level of the fibrous elements of the reticular layers; some adipocytes below the dermis are also damaged. On the other hand, no apparent alterations of the upper dermal areas and the epidermis can be detected. These features are further enhanced in the specimens corresponding to the photosensitised skin area (Figures 12 and 13 ): while the epidermis and the horny layer exhibit a normal structure, the dermis and some subcutaneous compartments are heavily damaged. Thus, the number z-M~~~~~~~ Figure 2 Tumour specimen obtained at 3 h after PDT (x 5500). Figure 3 Tumour specimen obtained at 24 h after PDT (x 5500). Mitochondria (m) are significantly swollen and optically empty,
The formation of numerous cytoplasmic vacuoles and a swollen while several vesicles are formed owing to the alteration of the nuclear membrane (arrows), with relatively well-preserved nuclei, Golgi apparatus and rough endoplasmic reticulum.
can be seen. Tumour specimen obtained at I h after PDT Figure 7 Tumour specimen obtained at 6 h after PDT ( x 14 000). The micrograph shows a large vesiculation in the ( x 11 000). The nuclear membrane shows evident blebs and cell nucleus, as well as some detachment of the perinuclear blunt protuberances with a strongly condensed chromatin. membrane. These features have been observed in only a few cells, Moreover, the mitochondria (m) are optically empty and heavily although such modified cells were present in many thin sections.
swollen, and the rough endoplasmic reticulum (R) is extensively
No similar feature was observed in control mice. altered.
Phototherapeutic activity of ZnODPc C Ometto et a! 1896 of the fibrous elements of the connective tissue is substantially reduced and the overall organisation is significantly perturbed; moreover, the adipose cells are damaged to a great extent so that their borders are no longer detectable. The skin of mice phototreated at 15 h or 24 h after injection of ZnODPc shows histological features identical with those of control unirradiated animals.
Discussion
Our findings on the biodistribution of Cremophor-delivered ZnODPc in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma are in good agreement with those obtained for other phthalocyanines in the same animal model (Segalla et al., 1994; Soncin et al., 1995b ) with regard to the timing and amount of maximal accumulation in the tumour (15-24 h after i.v. injection), the rate of plasma clearance and the high concentrations recovered from liver Figure 8 Tumour specimen obtained at 6 h after PDT ( x 30 000). The typical feature of this micrograph is the heavily condensed chromatin at one nuclear pole, in addition to the marked swelling and formation of gaps in the perinuclear membrane. Slight damage is detectable in the subcutaneous adipose layer epidermis; HB, hair bulb; SAL, subcutaneous adipose layer; SG, (x 360). D, dermis; E, epidermis; HB, hair bulb; SAL, sebaceous glands.
subcutaneous adipose layer; SG, sebaceous glands.
Phototherapoutic activity of ZnODPc C Ometto et al Figure 12 Histological features of an irradiated skin sample obtained from PDT-treated mice. The sample was taken at 3 h after the end of irradiation and shows a heavily damaged subcutaneous and dermal tissue, while the epidermis is still fairly well preserved ( x 230). D, dermis; E, epidermis; HF, hair follicle; SAL, subcutaneous adipose layer. Figure 13 Same sample as shown in Figure 12 . The greater magnification yields an evident indication that the horny layer and the underlying upper layers of the epidermis are not appreciably altered. The dermal structure appears to be markedly disorganised (x 580). D, dermis; E, epidermis; SG, sebaceous glands.
and spleen. The latter property is typical of hydrophobic dyes that are administered in association with lipid-type delivery systems and are largely eliminated from the organism through the bile-gut pathway (Jori, 1995) . This is further supported by the markedly lower amounts of ZnODPc recovered from kidneys. Moreover, the negligible uptake of this phthalocyanine in the brain is in line with the repeatedly observed inability of porphyrin compounds to cross the blood-brain barrier (Jori, 1995) ; as a consequence, one should discard any significant risk of toxic effects of ZnODPc at the level of the central nervous system. A comparative analysis of the data reported in Tables III and IV suggests that the pharmacokinetic behaviour of ZnODPc is independent of the injected dose at least within the range 0.37-1.46 ,mol kg-' On the other hand, ZnODPc exhibits an unusually high selectivity of tumour targeting, since no detectable amount of phthalocyanine was found in the peritumoral tissue, i.e. the muscle, at all monitored post-injection times and at the three drug doses examined in the present investigation. Although selectivity is not necessarily the most important determinant for the efficacy and safety of PDT treatments (Henderson and Dougherty, 1992; Ris et al., 1993) , it certainly represents an important factor in the choice of a tumour photosensitiser.
The present evidence suggests that the localisation of porphyrin derivatives in tumours is controlled by several different parameters (Jori, 1990; Pass, 1993; Penning and Dubbelman, 1994) . Recently, we have observed that the selectivity and efficiency of phthalocyanine accumulation in the MS-2 fibrosarcoma increases with an increasing degree of hydrophobicity of the dye and the extent of phthalocyanine associated with serum LDL (Soncin et al., 1995a) . In particular, Cremophor appears to promote a greater selectivity of tumour targeting by a given phthalocyanine compared with liposomal vesicles (Soncin et al., 1995b) , since it determines a larger release of the incorporated photosensitiser to LDL, probably owing to a specific interaction leading to an alteration of this component of the lipoprotein family (Kongshaug et al., 1991; Woodburn et al., 1994) . On these bases, the extremely high selectivity of ZnODPc uptake in the tumour can be related to its unusually high affinity for LDL, which is clearly expressed by the data on the distribution of this phthalocyanine among serum proteins (see Table I ). Similar (Maziere et al., 1991) . However, important vascular damage is detected at relatively short time intervals after the end of irradiation, which is remarkably different from that previously observed for other hydrophobic porphyrinoids, namely a well-preserved structure of blood capillaries for several hours after PDT (Zhou et al., 1988 (Zhou et al., , 1989 . Another peculiar feature of ZnODPc photosensitisation of tumours is represented by the appearance of some nuclear damage even at short post-irradiation times (see Figure 5 ). This observation would suggest the need for investigations aimed at defining whether ZnODPc-promoted photoprocesses have any mutagenic potential, in spite of the fact that such a possibility has never been reported for other phthalocyanines. Our observations would suggest that ZnODPc is also partitioned to a significant extent within endothelial cells, since the mitochondria of such cells appears to undergo some alterations already at 3 h after PDT. In any case, the mechanisms by which ZnODPc exerts its photosensitising action on tumour cells are certainly complex. Both random cell death and apoptosis are clearly involved, although the relative importance of the two processes cannot be defined from our ultrastructural analyses of irradiated samples of the MS-2 fibrosarcoma. Apparently, the occurrence of apoptosis is rather frequent, since unequivocal evidence of this modality of cell death is identifiable in most micrographs obtained from specimens of tumours taken at 1 -6 h after PDT (three mice at each time, eight or nine sections per mouse). The possibility that PDT triggers cell apoptosis has been now recognised by several authors (Agarwal et al., 1991; Zaidi et al., 1993; He et al., 1994) and recently demonstrated for liposome-delivered Zn(II)-phthalocyanine (Zhou et al., 1996) . Therefore, it is not surprising that both the above-mentioned modalities of cell death are caused by photoactivated ZnODPc. Apoptosis could make a major contribution to the overall phototherapeutic process, especially in those areas where tumour necrosis is less pronounced. This may possibly arise from an ,*4
Phototherapeutic activity of ZnODPc C Ometto et al 1898 inhomogeneous distribution of the phthalocyanine across the neoplastic tissue, so that there are some compartments in which the photosensitiser concentration is relatively small. This may explain the high phototherapeutic activity of ZnODPc.
One undesired side-effect induced by PDT with porphyrins and their analogues is the persistence of cutaneous photosensitivity for even a few weeks after systemic injection of the dye (Dougherty, 1993) . This effect has been ascribed to a prolonged retention of the photosensitiser in the skin, although some authors hypothesised (Zalar et al., 1977; Henderson, 1990) a correlation between plasma levels of the dye and skin photosensitivity. Our findings with ZnODPc support the latter hypothesis since (1) severe photosensitised damage to mouse skin occurs upon irradiation 3-6 h after injection time, when only low amounts of phthalocyanine are present in the cutaneous districts, while large levels are found in the plasma; (2) the photosensitivity disappears as the plasma levels of ZnODPc decrease (e.g. at 15-24 h after injection), even if essentially the same amount of phthalocyanine is now accumulated in the skin (see Table II ); and (3) histological examination of photosensitised skin shows that the damage is largely localised in the dermis and lower epidermis, while the upper epidermal layers are only slightly altered.
In conclusion, a proper choice of irradiation conditions, and particularly a suitable time interval between injection and PDT treatment, allow one to take full advantage of the potential of ZnODPc as a phototherapeutic agent for tumours by combining the efficient accumulation in and photosensitisation of the malignant lesion, the induction of different parallel mechanisms leading to tumour necrosis, the minimal risk of photodamaging the peritumoral tissues and the rapid disappearance of generalised skin photosensitivity.
